U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ACHIRAL
Molecular Formula C19H16F3N3O3
Molecular Weight 391.3438
Optical Activity NONE
Additional Stereochemistry Yes
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0
Stereo Comments AXIAL, R

SHOW SMILES / InChI
Structure of TAVAPADON

SMILES

CN1C(=O)NC(=O)C(C)=C1C2=C(C)C=C(OC3=NC=CC=C3C(F)(F)F)C=C2

InChI

InChIKey=AKQXQLUNFKDZBN-UHFFFAOYSA-N
InChI=1S/C19H16F3N3O3/c1-10-9-12(28-17-14(19(20,21)22)5-4-8-23-17)6-7-13(10)15-11(2)16(26)24-18(27)25(15)3/h4-9H,1-3H3,(H,24,26,27)

HIDE SMILES / InChI
Molecular Formula C19H16F3N3O3
Molecular Weight 391.3438
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Unknown
149124
Substance Class Chemical
Created
by admin
on Mon Mar 31 23:33:21 GMT 2025
Edited
by admin
on Mon Mar 31 23:33:21 GMT 2025
Record UNII
PT4P8MJP8L
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
TAVAPADON
INN   USAN  
Official Name English
(-)-1,5-DIMETHYL-6-(2-METHYL-4-((3-(TRIFLUOROMETHYL)-2-PYRIDINYL)OXY)PHENYL)-2,4(1H,3H)-PYRIMIDINEDIONE
Preferred Name English
tavapadon [INN]
Common Name English
CVL-751
Code English
2,4(1H,3H)-PYRIMIDINEDIONE, 1,5-DIMETHYL-6-(2-METHYL-4-((3-(TRIFLUOROMETHYL)-2-PYRIDINYL)OXY)PHENYL)-, (-)-
Systematic Name English
PF-06649751
Code English
TAVAPADON [USAN]
Common Name English
Code System Code Type Description
PUBCHEM
86764100
Created by admin on Mon Mar 31 23:33:21 GMT 2025 , Edited by admin on Mon Mar 31 23:33:21 GMT 2025
PRIMARY
NCI_THESAURUS
C174853
Created by admin on Mon Mar 31 23:33:21 GMT 2025 , Edited by admin on Mon Mar 31 23:33:21 GMT 2025
PRIMARY
SMS_ID
100000183608
Created by admin on Mon Mar 31 23:33:21 GMT 2025 , Edited by admin on Mon Mar 31 23:33:21 GMT 2025
PRIMARY
CAS
1643489-24-0
Created by admin on Mon Mar 31 23:33:21 GMT 2025 , Edited by admin on Mon Mar 31 23:33:21 GMT 2025
PRIMARY
EPA CompTox
DTXSID301337071
Created by admin on Mon Mar 31 23:33:21 GMT 2025 , Edited by admin on Mon Mar 31 23:33:21 GMT 2025
PRIMARY
DRUG BANK
DB14899
Created by admin on Mon Mar 31 23:33:21 GMT 2025 , Edited by admin on Mon Mar 31 23:33:21 GMT 2025
PRIMARY
USAN
EF-130
Created by admin on Mon Mar 31 23:33:21 GMT 2025 , Edited by admin on Mon Mar 31 23:33:21 GMT 2025
PRIMARY
FDA UNII
PT4P8MJP8L
Created by admin on Mon Mar 31 23:33:21 GMT 2025 , Edited by admin on Mon Mar 31 23:33:21 GMT 2025
PRIMARY
WIKIPEDIA
Tavapadon
Created by admin on Mon Mar 31 23:33:21 GMT 2025 , Edited by admin on Mon Mar 31 23:33:21 GMT 2025
PRIMARY
INN
10887
Created by admin on Mon Mar 31 23:33:21 GMT 2025 , Edited by admin on Mon Mar 31 23:33:21 GMT 2025
PRIMARY
Related Record Type Details
D(1B) DOPAMINE RECEPTOR
TARGET -> AGONIST
D(1A) DOPAMINE RECEPTOR
TARGET -> AGONIST
Related Record Type Details
Structure of TAVAPADON
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966